Clinical experience with spirapril in human hypertension

Area of Science:

• Pharmacology
• Cardiology
• Clinical Medicine

Background:

• Arterial hypertension is a significant global health concern.
• Effective and well-tolerated antihypertensive medications are crucial for patient management.
• Post-marketing surveillance provides real-world data on drug efficacy and safety.

Purpose of the Study:

• To evaluate the efficacy and tolerability of spirapril in a large patient cohort.
• To assess spirapril's effectiveness across different hypertension severities.
• To determine the real-world performance of spirapril in routine clinical practice.

Main Methods:

• Prospective, multicentre, post-marketing surveillance study.
• Involved 5000 patients with arterial hypertension.
• Primarily used a single daily dose of 6 mg spirapril, with data collected by internists and general practitioners.

Main Results:

• Spirapril demonstrated significant reductions in systolic and diastolic blood pressure.
• Achieved high responder rates: 89.4% for systolic and 85.4% for diastolic blood pressure.
• Showed good tolerability with a low incidence of side effects (2.9%), including minimal coughing (0.88%).

Conclusions:

• Spirapril is a highly effective antihypertensive agent.
• Its efficacy is correlated with baseline blood pressure, proving effective even in severe hypertension.
• Spirapril offers good tolerability, making it a valuable treatment option.